Real-time PCR of CD146 mRNA in peripheral blood enables the relative quantification of circulating endothelial cells and is an indicator of angiogenesis

Por Fürstenberger, G, von Moos, R, Senn, H-J, Boneberg, E-M
Publicado em 2005

Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer

Por Fürstenberger, G, von Moos, R, Lucas, R, Thürlimann, B, Senn, H-J, Hamacher, J, Boneberg, E-M
Publicado em 2006

Phase I study of olaparib in combination with liposomal doxorubicin in patients with advanced solid tumours

Por Del Conte, G, Sessa, C, von Moos, R, Viganò, L, Digena, T, Locatelli, A, Gallerani, E, Fasolo, A, Tessari, A, Cathomas, R, Gianni, L
Publicado em 2014

Phase II study of capecitabine and oxaliplatin given prior to and concurrently with preoperative pelvic radiotherapy in patients with locally advanced rectal cancer

Por Koeberle, D, Burkhard, R, von Moos, R, Winterhalder, R, Hess, V, Heitzmann, F, Ruhstaller, T, Terraciano, L, Neuweiler, J, Bieri, G, Rust, C, Toepfer, M
Publicado em 2008

Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study

Por Strasser, F, Lutz, T A, Maeder, M T, Thuerlimann, B, Bueche, D, Tschöp, M, Kaufmann, K, Holst, B, Brändle, M, von Moos, R, Demmer, R, Cerny, T
Publicado em 2008